That “someone” — Bitcoiner Jameson Lopp — argues he was championing a much-needed fix to one of Bitcoin’s testnets.
test News
- News11704
- News
With the toolkit, developers and security researchers can test, analyze and debug transactions via controlled private fork chains from the Ethereum mainnet.
6507 - News
GPT-4 completed many of the tests within the top 10% of the cohort, while the original version of ChatGPT often finished up in the bottom 10%.
30149 - News
Matter Labs chief product officer Steve Newcomb emphasized to Cointelegraph that the launch of its L3 prototype will significantly improve the performance of its L2 solution.
5747 - Interview
Last year, the Akutars NFT collection sold out 15,000 tokens, but a major big saw $33 million worth of Ether (ETH) generated from sales locked into an inaccessible smart contract.
2686 - News
With the Goerli merge going successfully, there is growing confidence that there will be no further delays to the Ethereum Merge set for mid-September.
13101 - News
Merge trials on testnets are essential to allow Ethereum developers and independent project developers to understand what they can expect when the actual Merge takes place.
11202 - News
The difficulty bomb has been successfully delayed according to core dev Tim Beiko and Ethereum ecosystem developer Nethermind.
11305 - News
From July 3, the four-week window for application developers and exchanges to test the upcoming Cardano upgrade begins before it’s launched onto the mainnet.
14141 - News
The Sepolia testnet is the next in line after Ropsten to undergo a merge trial run since its Beacon Chain is now live and ready to give developers valuable information leading up to the real thing.
9964 - News
The Kiln testnet is the final public testing phase before the long-awaited Ethereum ‘Merge’ and the end of proof-of-work consensus.
15767 - News
“QKD is the only solution that has been mathematically proven to defend against a potential quantum computing-based attack,” JPMorgan emphasized in its announcement.
19375 - News
Julia Cheek, CEO of at-home medical testing company Everlywell, called U.S. lab testing problematic.
2942